RVL Pharmaceuticals
PublicRVL Pharmaceuticals is now publicly traded
The data on this page reflects RVL Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Oct 17, 2018
Last Round
Private Placement
Aug 15, 2023
Total Funding Raised
$236.93M
Company Overview
RVL Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes eyecare and medical aesthetics products, including its FDA-approved product UPNEEQ® for droopy eyelids.
AI Layer
Non-AI
Keywords
RVL Pharmaceuticals Comparables
Compare RVL Pharmaceuticals with similar companies based on industry and business-model similarity.
No public comparables are available for RVL Pharmaceuticals. Request access to learn about comparables coverage.
Request accessRVL Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Aug 15, 2023 | ||||
| Private Placement | Aug 8, 2022 | ||||
| Debt | Aug 4, 2022 | ||||
| Follow-on Offering | Oct 12, 2021 | ||||
| Debt | Oct 7, 2021 | ||||
Follow-on Offering | Jul 16, 2020 |
Key People
Founding team and executive leadership
RVL Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| H.C. Wainwright & Co. | Follow-on Offering |
| Athyrium Capital Management | Private Placement, Debt |
| RBC Capital Markets | IPO |
| Wells Fargo Securities | IPO |
| Avista Capital Partners | Debt, IPO, Private Placement |
RVL Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access